Business
Premier Biomedical Updates “Stock Day” Listeners on 2017 Accomplishments; Sketches Outline Towards $5 Billion CBD Oil Market Penetration
Premier Biomedical Updates “Stock Day” Listeners on 2017 Accomplishments; Sketches Outline Towards $5 Billion CBD Oil Market Penetration.
About this update from Premier Biomedical Inc
[{"type":"text","content":"\n\n PHOENIX, Jan. 17, 2018 (GLOBE NEWSWIRE) -- The Uptick Newswire “Stock Day” podcast keeps investors up to date on the latest penny stock news by bringing transparency in the micro-cap side of the market. Connect with “Stock Day” and to over 600+  CEO interviews on the OTC, Pink Sheets and micro-cap news from around the world by following Stock Day’s YouTube, Google Play and iTunes. Everett Jolly, CEO and host of “Stock Day”, had received many emails and calls to have as a return guest, William A. Hartman, CEO of Premier Biomedical Inc. (OTC:BIEI) (“Company”), which is rapidly growing in the hemp oil pain relief industry.\n Starting off the interview, Mr. Hartman discussed the positive achievements that Premier Biomedical attained throughout 2017. Premier Biomedical had promising results with their R&D Cancer Research efforts, outperforming the leading anti-cancer drug currently on the market in animal testing.  Lacking the funding required to complete the development of this anti-cancer drug, Premier Biomedical had to put this uniquely promising research on hold in order to develop a revenue-producing technology product which would provide a steady cash flow. Even though the funding for the cancer R&D has slowed, the Company has not stopped research & development, with the most recent filing of a patent application in this potentially lucrative area of the medical market.  Mr. Hartman briefly touched on the recently filed patent application involving the use of a laser procedure to destroy disease antigens which would be a very promising development for medical science in the future. Industry analysts predict that the medically promising hemp oil topical pain product industry could grow into an estimated $5 Billion market by 2025, prompting Premier Biomedical’s leap into the hemp oil pain relief product arena.  With the successful launch of their first product, a topical pain patch, in the first quarter of 2017, Premier Biomedical had to search long and hard for a manufacturing source that was able to keep up with the Company's production volume. Throughout 2017, Premier Biomedical launched a total of five new hemp oil topical pain relief products including a 50 mg, 96-hour pain patch, a hemp oil based roll-on, a water based roll-on, ...